Vivus

Pharma

ICER put four recent obesity meds under a microscope

Novo Nordisk’s weight loss newcomer Wegovy may not be the thriftiest obesity med on the market, but its efficacy and safety look good, ICER says.
Fraiser Kansteiner Jul 13, 2022 9:30am

FDA rebukes Metuchen for 'misleading' Stendra ads

Aug 29, 2019 4:03pm

FDA's promo police ding Vivus for misleading Qsymia webpage

Jun 6, 2019 12:43pm

Vivus, diving into CF, backs stadium step-climbing fundraiser

Sep 27, 2018 11:05am

Novo preps big obesity push, undeterred by its rivals' fates

Nov 21, 2017 11:57am

Sanofi wipes its hands of Vivus ED med Stendra

Mar 29, 2017 9:55am